MARLBOROUGH, Mass.–(BUSINESS WIRE)–#ESG–Hologic, Inc. (Nasdaq: HOLX) announced today the online publication of “A Global Force for Good,” a report detailing the Company’s environmental, social and governance (ESG) achievements in 2021.
The report highlights how Hologic’s purpose – to enable healthier lives everywhere, every day – makes a positive difference for women, their families and their communities worldwide. The impact includes:
“We know we are making the world a better place, we believe we are a model for all that is good in private enterprise, and we, as a purpose-driven company with an extraordinarily engaged team, feel proud and honored to share our story with you through the new sustainability report,” said Steve MacMillan, Hologic’s chairman, president and CEO.
Hologic has increasingly gained attention for its ESG leadership. Last year, the Company’s sustainability accomplishments were a key reason it received recognition from Dow Jones, Investors Business Daily, Newsweek, and the Drucker Institute.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
Forward-Looking Statements
This news release may contain forward-looking information that involves risks and uncertainties, including statements about Hologic’s sustainability efforts. There can be no assurance that these efforts will be successful, benefit the Company and its stockholders, or improve over time. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any changes in expectations or events, conditions or circumstances on which any such data or statements are based.
SOURCE: Hologic, Inc.
Contacts
Investors:
Ryan Simon
+1 858.410.8514 (direct)
ryan.simon@hologic.com
Media:
Jane Mazur
+1 508.263.8764 (direct)
+1 585.355.5978 (mobile)
jane.mazur@hologic.com
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…